Antibody (AbG) Analysis
AbG refers to antibody analysis — the laboratory and clinical study of immunoglobulins (antibodies) to detect, quantify, or characterize the immune response. It is a cornerstone of clinical immunology, infectious disease, autoimmune diagnostics, and transfusion medicine.
1. What Are Antibodies?
Antibodies (immunoglobulins, Ig) are glycoproteins produced by B lymphocytes/plasma cells in response to antigens. Each antibody molecule consists of:
- 2 heavy chains + 2 light chains linked by disulfide bonds
- Variable (V) regions — form the antigen-binding sites (paratopes)
- Constant (C) regions — determine effector function and class
- Fab fragment — antigen-binding portion
- Fc fragment — interacts with complement and Fc receptors
The diversity of antibodies arises from V-D-J recombination of gene segments on chromosomes 2 (κ), 14 (heavy chain), and 22 (λ) (Harrison's, p. 3319).
2. Classes of Immunoglobulins
| Class | Key Features | Normal Serum Level |
|---|
| IgG | Most abundant; 4 subclasses; crosses placenta; secondary immune response | 700–1600 mg/dL |
| IgM | Pentameric; first antibody in primary response; best at activating complement | 40–230 mg/dL |
| IgA | Found in secretions (saliva, breast milk, tears); dimer in mucosa | 70–400 mg/dL |
| IgE | Mediate allergic reactions; binds mast cells/basophils; very low serum levels | 0.02–0.05 mg/dL |
| IgD | Surface receptor on naive B cells; function not fully elucidated | Trace |
3. Methods of Antibody Analysis
| Method | Principle | Use |
|---|
| ELISA / EIA | Enzyme-labeled antigen/antibody detection | Quantification of specific antibodies (HIV, Lyme, COVID-19) |
| Immunofluorescence (IFA) | Fluorescent-tagged antibodies visualize targets | ANA screening, viral serology |
| Western/Immunoblot | Antibodies detected against separated protein bands | Confirmatory test (HIV, Lyme IgG/IgM) |
| Serum Protein Electrophoresis (SPEP) | Separates proteins by charge/size | Detects M-protein in myeloma |
| Immunofixation (IFE) | Identifies Ig class/light chain type | Confirms monoclonal gammopathy |
| Flow Cytometry | Cell-surface antibody markers | B-cell subsets, CD markers |
| Complement Fixation | Antibody-complement interaction | Older viral serology |
| Agglutination / Hemagglutination | Antibody crosslinks particulate antigens | ABO blood typing, Widal test |
| Neutralization Assay | Antibody blocks pathogen infectivity | Vaccine efficacy studies |
| Nephelometry/Turbidimetry | Light scatter by antigen-antibody complexes | Quantitative Ig levels (IgG, IgA, IgM) |
4. Clinical Examples of Antibody Analysis
A. Infectious Disease Serology
Lyme Disease (Two-Tiered Testing)
A standardized 2-tiered approach is used:
- Tier 1: EIA or IFA (screening) — high sensitivity
- Tier 2: IgM and IgG immunoblots, or a second EIA — improves specificity
- IgM rises early (weeks 1–4) but can give false positives if used alone
- IgG seropositivity confirms disease in later stages (weeks to months)
- IgG seronegativity in an untreated patient with months of symptoms essentially rules out Lyme disease (Guidelines for Prevention, Diagnosis and Treatment of Lyme Disease, p. 10)
HIV Testing
- 4th-generation assays detect anti-HIV IgG/IgM + p24 antigen simultaneously
- Confirmatory: HIV-1/HIV-2 antibody differentiation immunoassay
Hepatitis B
| Marker | Interpretation |
|---|
| HBsAg+ | Active infection |
| Anti-HBs (IgG)+ | Immunity (vaccination or recovery) |
| Anti-HBc IgM+ | Acute infection |
| Anti-HBc IgG+ | Past or chronic infection |
B. Autoimmune Disease
| Antibody | Disease Association |
|---|
| ANA (anti-nuclear Ab) | SLE screening |
| Anti-dsDNA | SLE (high specificity) |
| Anti-Sm | SLE (most specific) |
| Anti-Ro/La (SSA/SSB) | Sjögren's syndrome, neonatal lupus |
| RF (IgM anti-IgG) | Rheumatoid arthritis |
| Anti-CCP | RA (high specificity) |
| Anti-GBM | Goodpasture syndrome |
| ANCA (PR3, MPO) | Vasculitis (GPA, MPA) |
| Anti-TPO, Anti-TG | Hashimoto's thyroiditis |
| Anti-TSH-R | Graves' disease |
C. Hematology / Transfusion Medicine
- Direct Coombs Test (DAT): Detects IgG or complement bound to patient's RBCs → used in autoimmune hemolytic anemia, hemolytic transfusion reactions, HDN
- Indirect Coombs Test (IAT): Detects free antibodies in patient serum that react with test RBCs → pre-transfusion crossmatch, antibody screening
- ABO/Rh Typing: Agglutination reactions with known antisera
D. Allergy / Hypersensitivity
- Total IgE: Elevated in atopic conditions
- Specific IgE (RAST/ImmunoCAP): Identifies allergen-specific IgE (e.g., peanut, grass pollen, latex)
- Skin prick testing: In vivo equivalent of IgE-mediated response
E. Immunodeficiency
| Deficiency | Antibody Findings |
|---|
| X-linked agammaglobulinemia (XLA) | Absent all Ig classes |
| Common Variable Immunodeficiency (CVID) | Low IgG, IgA, IgM |
| Selective IgA deficiency | Isolated IgA absent/low |
| Hyper-IgM syndrome | High IgM, absent IgG/IgA/IgE |
F. Monoclonal Gammopathy
- SPEP: Detects M-spike (homogeneous band in gamma region)
- IFE: Confirms monoclonal IgG κ, IgA λ, etc.
- Serum free light chains (κ/λ ratio): Sensitive marker in myeloma, AL amyloidosis
- Examples: Multiple myeloma, MGUS, Waldenström's macroglobulinemia
5. Interpretation Principles
- Sensitivity vs. Specificity: IgM is more sensitive early; IgG is more specific in chronic/convalescent phases
- Seroconversion window: A negative result in the acute window does NOT rule out infection
- Clinical correlation is essential: Predictive value depends on pre-test probability (Lyme Guidelines, p. 10)
- Paired sera: 4-fold rise in antibody titer between acute and convalescent samples confirms recent infection
- Prozone effect: Very high antibody concentrations can cause falsely negative results due to antigen excess
Antibody analysis is one of the most versatile tools in medicine, spanning from basic blood typing to complex autoimmune panels and vaccine immunogenicity studies. The choice of assay and the interpretation of results must always be integrated with the clinical picture.